შაბათი, მაისი 2, 2026
- Advertisement -
Google search engine
Global Ingredient Risk Index Excipient

Potassium Sorbate

Potassium (E)-hexa-2,4-dienoate

Also known as: potassium sorbate, sorbic acid potassium salt, E202

LOW RISK 2.5/10 How?

This ingredient is classified as unclassified risk (GIRI score: 2.5/10).

02

Safety Profile

Known Safety Concerns

  • In vitro genotoxicity signals -- not confirmed in vivo at food use levels
  • Skin and hypersensitivity reactions in some individuals
  • Better safety profile than sodium benzoate (no benzene formation with vitamin C)
  • GRAS at typical food and supplement use levels

Contraindications

  • In vitro genotoxicity signals -- not confirmed in vivo at food use levels
  • Skin and hypersensitivity reactions in some individuals
═══════════════════════════════════════════════════════════════════════ -->
03

Interactions

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
04

Evidence and Scientific Findings

Overview

Ingredient Overview

Potassium sorbate is a widely used preservative in liquid supplements, gummies, and functional foods. Generally recognized as safe (GRAS). It is metabolized as a fatty acid by the body. Some individuals experience skin reactions or allergic responses. In vitro studies have raised genotoxicity questions but in vivo studies have not confirmed significant harm at food use levels. Better safety profile than sodium benzoate.

Classification

Biological and Chemical Classification

Scientific Name
Potassium (E)-hexa-2,4-dienoate
Mechanism

Mechanism of Action

Information not yet available for this ingredient profile.

Clinical Evidence

Clinical Evidence of Effectiveness

Information not yet available for this ingredient profile.

Pharmacokinetics

Pharmacokinetics

Information not yet available for this ingredient profile.

Dosage

Recommended Dosage

Information not yet available for this ingredient profile.

═══════════════════════════════════════════════════════════════════════ -->
05

SETI — Scientific Evidence Transparency Index

SETI Score 50/100
Risk Level High risk
Scientific Confidence Low
Evidence Strength Limited
Key Benefit Excipient
Key Safety Concern In vitro genotoxicity signals -- not confirmed in vivo at food use levels
Evidence Reviewed 10 PubMed studies
Scientific Confidence Low
Based on study quality, consistency, and recency

Executive Summary — Ingredient Assessment

SETI Score 50/100
Risk Level High risk
Evidence Strength Limited
Main Benefit Excipient
Main Safety Concern In vitro genotoxicity signals -- not confirmed in vivo at food use levels
Ingredient Potassium Sorbate
Scientific name Potassium (E)-hexa-2,4-dienoate
Scientific Evidence Overview
  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or RCT)
  • Main clinical benefit observed: Excipient
  • Evidence consistency: High consistency across studies (100%)
Safety Signals
  • In vitro genotoxicity signals -- not confirmed in vivo at food use levels
  • Skin and hypersensitivity reactions in some individuals
  • Better safety profile than sodium benzoate (no benzene formation with vitamin C)
  • GRAS at typical food and supplement use levels
Evidence Strength Limited
Final Scientific Assessment

The available scientific evidence for Potassium Sorbate indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.

Ingredient Potassium Sorbate
Evidence reviewed 10 peer-reviewed studies (last 10 years)
Scientific name Potassium (E)-hexa-2,4-dienoate
50 /100

Total SETI Score

High risk
Evidence quality 10/40
Evidence consistency 20/20
Safety signals 0/20
Study recency 10/10
Evidence transparency 10/10

Evidence Summary

  • 10 studies reviewed
  • 0 high-quality studies (meta-analysis or systematic review)
  • 0 studies identified benefits or no safety concern (GREEN)
  • 10 studies reported limited or advisory safety evidence (YELLOW)

Evidence Policy

Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.

Last updated: 24 მარ 2026, 09:34

Evidence Distribution

10 Other / unclassified
  1. Observational / other LOW evidence YELLOW
    Main effects of ascorbic acid levels and organic acid type on physicochemical properties, microbial populations, texture, and biogenic amine formation in sucuk. ↗
    Journal J Sci Food Agric
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Bu0131u00e7akcu0131 G et al.. Main effects of ascorbic acid levels and organic acid type on physicochemical properties, microbial populations, texture, and biogenic amine formation in sucuk.. J Sci Food Agric. 2026. PMID:41821176.
  2. Observational / other LOW evidence YELLOW
    Natural food-derived antimicrobials against beer spoilage microorganisms. ↗
    Journal Appl Microbiol Biotechnol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Liu C et al.. Natural food-derived antimicrobials against beer spoilage microorganisms.. Appl Microbiol Biotechnol. 2026. PMID:41813865.
  3. Observational / other LOW evidence YELLOW
    Potassium sorbate instigates sub-chronic cardiotoxicity via dysregulating TLR4/MyD88 and NF-u03baB pathway: A biochemical, radiological, histological, and computational validation. ↗
    Journal Tissue Cell
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Alsubki R et al.. Potassium sorbate instigates sub-chronic cardiotoxicity via dysregulating TLR4/MyD88 and NF-u03baB pathway: A biochemical, radiological, histological, and computational validation.. Tissue Cell. 2026. PMID:41806634.
  4. Observational / other LOW evidence YELLOW
    In Vitro Effects of Twelve Food Additives on Gut Microbiome and Its Fibre Fermentation Capacity in Adults with Crohn's Disease in Remission… ↗
    Journal Nutrients
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Alessa H et al.. In Vitro Effects of Twelve Food Additives on Gut Microbiome and Its Fibre Fermentation Capacity in Adults with Crohn's Disease in Remission and Healthy Controls.. Nutrients. 2026. PMID:41754185.
  5. Observational / other LOW evidence YELLOW
    Bactericidal and anti-virulence effects of Melaleuca alternifolia essential oil against foodborne pathogens: in vitro and milk matrix assay. ↗
    Journal Lett Appl Microbiol
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Magna LR et al.. Bactericidal and anti-virulence effects of Melaleuca alternifolia essential oil against foodborne pathogens: in vitro and milk matrix assay.. Lett Appl Microbiol. 2026. PMID:41733458.
  6. Observational / other LOW evidence YELLOW
    Investigating the Shelf-Life Extension of Shrimp Surimi Using a Polysaccharide-Based Film from Alpinia oxyphylla. ↗
    Journal Foods
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Wang M et al.. Investigating the Shelf-Life Extension of Shrimp Surimi Using a Polysaccharide-Based Film from Alpinia oxyphylla.. Foods. 2026. PMID:41683116.
  7. Observational / other LOW evidence YELLOW
    Preservatives in Leave-On Cosmetics Available on the Dutch Market. ↗
    Journal Contact Dermatitis
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    de Groot AC et al.. Preservatives in Leave-On Cosmetics Available on the Dutch Market.. Contact Dermatitis. 2026. PMID:41638886.
  8. Observational / other LOW evidence YELLOW
    Effects of various concentrations and volumes of potassium sorbate on colostrum bacterial contamination over time at ambient and refrigeration temperatures. ↗
    Journal J Dairy Sci
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Denholm KS et al.. Effects of various concentrations and volumes of potassium sorbate on colostrum bacterial contamination over time at ambient and refrigeration temperatures.. J Dairy Sci. 2026. PMID:41570909.
  9. Observational / other LOW evidence YELLOW
    Synthesis, Characterization, and Anti-Listerial Activity of Chitosan-Stabilized Selenium Nanoparticles. ↗
    Journal J Food Sci
    Year 2026
    Study type Observational / other
    Evidence strength LOW evidence
    Anand D et al.. Synthesis, Characterization, and Anti-Listerial Activity of Chitosan-Stabilized Selenium Nanoparticles.. J Food Sci. 2026. PMID:41549643.
  10. Observational / other LOW evidence YELLOW
    Application of Mulberry (Morus nigra) Anthocyanin Extract Combined with Carboxymethyl Chitosan for Postharvest Preservation of Strawberry (Fragaria x ananassa). ↗
    Journal Curr Issues Mol Biol
    Year 2025
    Study type Observational / other
    Evidence strength LOW evidence
    Zhou B et al.. Application of Mulberry (Morus nigra) Anthocyanin Extract Combined with Carboxymethyl Chitosan for Postharvest Preservation of Strawberry (Fragaria x ananassa).. Curr Issues Mol Biol. 2025. PMID:41614759.
═══════════════════════════════════════════════════════════════════════ -->
06

Score Transparency

Q × L × D × S × 10 = 2.5 / 10

The GIRI Score is the product of four independently computed evidence components, each normalised to 0–1, then scaled to 0–10. Every component is derived exclusively from peer-reviewed references and regulatory data — no editorial judgement is applied.

Q
Evidence Quantity 0 / 10
0%

0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.

Method: Q = number of approved references ÷ 10 (capped at 1.0)

L
Evidence Quality 5 / 10
50%

Limited — mostly case reports or animal studies

Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.

D
Evidence Direction 5 / 10
Benefit
Risk
50%

Mixed or neutral — roughly equal benefit and risk signals

Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.

S
Safety Signals 5 / 10
50%

One or more monitoring-level safety signals active

Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.

0Q × 5L × 5D × 5S = 2.5 / 10

Final GIRI Score for Potassium Sorbate. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Full methodology & data sources

The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.

  • References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
  • Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
  • Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
  • Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
07

Risk Level Classification

LOW RISK 2.5/10

Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.

LOW
0–3.0
MODERATE
3.0–5.5
HIGH
5.5–7.5
CRITICAL
7.5–10
2.5

The score pin shows exactly where this ingredient falls on the fixed risk scale.

What drove the Low classification for Potassium Sorbate

GIRI Score 2.5 / 10

A score of 2.5 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.

Evidence Quantity (Q) 0 / 10 refs

0 approved references.

Evidence Quality (L) 50%

Limited — mostly case reports or animal studies (Level 4–5).

Evidence Direction (D) 50% toward risk

Neutral or mixed — benefit and risk signals roughly balanced.

Safety Signals (S) 0 active signals

No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.

Regulatory Status No restrictions found

No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).

How are the Low / Moderate / High / Critical thresholds defined?

The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:

LevelScoreMeaning
LOW0.0 – 2.9Sparse or predominantly beneficial evidence. No active safety alerts.
MODERATE3.0 – 5.4Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups.
HIGH5.5 – 7.4Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended.
CRITICAL7.5 – 10Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision.

Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.

შენიექიმი
sheniekimi.ge · PHIG
გამარჯობა 👋
სასურველი სერვისი აირჩიეთ ქვემოთ
⚡ გადაუდებელი შემთხვევა?
მყისიერი სამედიცინო დახმარება
📞 112
🩺
სიმპტომების შეფასება
150 კლინიკური სცენარი · WHO · AHA · NICE · 29 CDR
💉
ვაქცინაციის კალენდარი
WHO · ECDC · NCDC საქართველო 2025
💊
დანამატების შემოწმება
supplement.ge — 2,095 ინგრედიენტი
ℹ️ეს სისტემა ახდენს ტრიაჟს — არა დიაგნოზს. ყოველი გადაწყვეტილება დაფუძნებულია WHO, AHA, NICE, BTS სახელმძღვანელოებზე. ექიმის კონსულტაცია სავალდებულოა.
პირადი ინფორმაცია
სიმპტომების ზუსტი შეფასებისთვის შეიყვანეთ ასაკი და სქესი
👤სავალდებულო
📏 ანთროპომეტრია
სიმაღლე · წონა · BMI — არასავალდებულო
🩺 სასიცოცხლო მაჩვენებლები
წნევა · პულსი · ტემპერატურა · SpO2 — არასავალდებულო
ნორმა: 90–129
ნორმა: 60–100
36–37.2
12–20
≥95%
სიმპტომების შეფასება
აირჩიეთ სცენარი სისტემის მიხედვით
🔍
კითხვა 1 / 1
📋 მტკიცებულებითი საფუძველი
World Health Organization (WHO) — IMAI სახელმძღვანელო
American Heart Association (AHA) / ACC
National Institute for Health and Care Excellence (NICE)
ICD-11 (2025) · World Health Organization
ეს ინსტრუმენტი ახდენს ტრიაჟს — არა დიაგნოზს. სიმპტომები შეიძლება მიუთითებდეს — ეს არ ნიშნავს, რომ დაავადება გაქვთ. ექიმის კონსულტაცია სავალდებულოა.
📰 სიახლეები ყველა ›
ვაქცინაციის კალენდარი
აირჩიეთ ასაკობრივი ჯგუფი
WHO ECDC NCDC 2025
📚წყარო: NCDC საქართველო 17.09.2025 · WHO · ECDC
ასაკობრივი ჯგუფი
📚წყარო: NCDC საქართველო 17.09.2025 · WHO · ECDC
📰 ვაქცინაციის სიახლეები ყველა ›
დანამატების შემოწმება
გადადით supplement.ge-ზე და შეამოწმეთ ნებისმიერი პროდუქტი
SUPPLEMENT.GE
საქართველოს სასურსათო დანამატების უსაფრთხოების შემოწმების სისტემა
📊 2,095 ინგრედიენტი 📦 688 პროდუქტი
supplement.ge-ზე გადასვლა
ახალი ფანჯარა გაიხსნება
რას შეგიძლიათ შეამოწმოთ
🔬
ინგრედიენტის შემოწმება
NIH · EU · FDA · Health Canada მონაცემები
📷
ეტიკეტის სკანირება
AI ამოიცნობს ყველა ინგრედიენტს ფოტოდან
🌍
ქვეყნის მიხედვით სტატუსი
რეგულაცია 14 ქვეყანაში — აშშ, ევროკავშირი, კანადა
⚠️
წამალთან ინტერაქცია
აუცილებელი გაფრთხილებები მიმდინარე მკურნალობისას
✅ supplement.ge — საქართველოში ერთადერთი სრული სისტემა დანამატების უსაფრთხოების შესაფასებლად, PHIG-ის (საზოგადოებრივი ჯანდაცვის ინსტიტუტის) კონტროლით.